Furthermore, it has been shown that IFN signaling has a central role in SLE skin pathology as the IFN signature correlates with cutaneous disease activity in SLE [24], and IFN pathways contribute to enhancing apoptosis of skin cells interfering with the protective Langerhans cell–keratinocytes axis [25]. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.